SOLUS: an innovative multimodal imaging system to improve breast cancer diagnosis through diffuse optics and ultrasounds
Antonio Pifferi,Alberto Dalla Mora,Laura Di Sieno,Edoardo Ferocino,Alberto Tosi,Enrico Conca,Vincenzo Sesta,Andrea Giudice,Alessandro Ruggeri,Simone Tisa,Alexander Flocke,Bogdan Rosinski,Jean-Marc Dinten,Mathieu Perriollat,Christophe Fraschini,Hélène Sportouche,Simon Arridge,Giuseppe Di Sciacca,Andrea Farina,Pietro Panizza,Elena Venturini,Peter Gordebeke,Pamela Zolda,Paola Taroni
DOI: https://doi.org/10.1117/12.2576778
2021-03-05
Abstract:To improve non-invasively the specificity in the diagnosis of breast cancer after a positive screening mammography or doubt/suspicious ultrasound examination, the SOLUS project developed a multimodal imaging system that combines: Bmode ultrasound (US) scans (to assess morphology), Color Doppler (to visualize vascularization), shear-wave elastography (to measure stiffness), and time domain multi-wavelength diffuse optical tomography (to estimate tissue composition in terms of oxy- and deoxy-hemoglobin, lipid, water, and collagen concentrations). The multimodal probe arranges 8 innovative photonic modules (optodes) around the US transducer, providing capability for optical tomographic reconstruction. For more accurate estimate of lesion composition, US-assessed morphological priors can be used to guide the optical reconstructions. Each optode comprises: i) 8 picosecond pulsed laser diodes with different wavelengths, covering a wide spectral range (635-1064 nm) for good probing of the different tissue constituents; ii) a large-area (variable, up to 8.6 mm2 ) fast-gated digital Silicon Photomultiplier; iii) the acquisition electronics to record the distribution of time-of-flight of the re-emitted photons. The optode is the basic element of the optical part of the system, but is also a stand-alone, ultra-compact (about 4 cm3 ) device for time domain multi-wavelength diffuse optics, with potential application in various fields.